Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Ad image

Growing interest in genAI in APAC and more briefings

MONews
3 Min Read

Report: APAC leaders invest more in genAI

Investments in generative AI technologies will increase in the Asia Pacific region in the coming years.

In the ninth edition of Royal Philips’ Future Health Index report, more than six in 10 APAC leaders surveyed said they plan to invest in genAI in the next three years. Today, nearly 40% have already invested in the technology.

While there is great excitement about the potential of AI in healthcare, nearly all leaders surveyed in the region said they are deeply concerned that “data bias in AI applications will widen gaps in health outcomes.”

To mitigate risks, leaders are working to increase transparency around AI, ensure diversity in the use of data and AI, provide ongoing AI education and training, and implement policies for the ethical use of data and AI.


Amazon’s genAI powers Korea’s new medical coder.

J&P Medi, a South Korean clinical data solutions provider, has unveiled a new generative AI-based medical coder on its cloud-based clinical trial data management platform.

Maven Coder Express is built using the Amazon Bedrock genAI service on Amazon Web Services, which automates data collection, discovery, rapid augmentation, and citation.

It runs on three AI models: Anthropic’s Claude 3.5 Sonnet, Claude 3 Haiku, and Amazon Titan Text Embedding v2. It also supports 13 languages, including Korean, English, German, Japanese, and Chinese.

The genAI-based medical coder is certified as a MedDRA coder by the International Society of Medical Terminology.Because the medical coding results are highly accurate and consistent.


Bayada Korea and Kakao Healthcare Join Hands to Build Digital Diabetes Service

Kakao Healthcare, Kakao’s digital health subsidiary, recently partnered with Bayada Home Healthcare to improve patients’ ability to manage their health at home.

The plan is to build online and offline consultation channels using Kakao Healthcare’s AI-based digital diabetes management service. Pasta. The service uses AI to provide smart recommendations for managing an individual’s blood sugar levels, and connects to a continuous glucose monitoring device to track and analyze them.

Additionally, this collaboration aims to expand pasta services overseas by leveraging Bayada’s international network.

Share This Article